Serotonin model of schizophrenia: emerging role of glutamate mechanisms

  title={Serotonin model of schizophrenia: emerging role of glutamate mechanisms},
  author={George K. Aghajanian and Gerard J. Marek},
  journal={Brain Research Reviews},

Figures from this paper

The psychotomimetic effects of PCP , LSD and MDMA : Pharmacological models of schizophrenia ?

The primary question addressed herein, whether PCP-induced psychosis is a valid model of schizophrenia, gives rise to additional questions about the validity of ketamine challenge at subanaesthetic doses in humans as a model of PCP psychosis, and in turn, questions aboutThe validity of drug-induced changes in non-human animals (rodents, monkeys) treated with PCP and its analogues (ketamine or dizocilpine [MK-801]) as models of PCPs psychosis.

Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex

The results from these experiments do not support the idea that 5-HT2ARs elicit the release of an excitatory retrograde messenger nor that they activate thalamocortical afferents, the two dominant hypotheses, and suggest that5-HT 2ARs facilitate intrinsic networks within the PFC.

Identification of a Novel Serotonin / Glutamate Receptor Complex Implicated in Psychosis

It is shown that the mGluR2 interacts via specific transmembrane helix domains with the 2AR, a member of an unrelated G protein-coupled receptor (GPCR) family, to form functional complexes in brain cortex, and represents a promising new target for the treatment of psychosis.

Identification of a serotonin/glutamate receptor complex implicated in psychosis

It is shown that the mGluR2 interacts through specific transmembrane helix domains with the 2AR, a member of an unrelated G-protein-coupled receptor family, to form functional complexes in brain cortex that may be involved in the altered cortical processes of schizophrenia.

Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.

Recent advances in understanding hallucinogen drug action are reviewed through characterization of structure, neuroanatomical location, and function of the 5-HT2A receptor.

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

The LSD-induced psychosis is a useful model to test the therapeutic efficacy of potential novel antipsychotic drugs, particularly drugs with dual serotonergic and dopaminergic (DA) mechanism or acting on TAAR1 receptors.

Role of the serotonin 5-HT(2A) receptor in learning.

  • J. Harvey
  • Psychology, Biology
    Learning & memory
  • 2003
It was concluded that the 5-HT2A receptor demonstrates constitutive activity, and that variations in this activity can produce profound alterations in cognitive states.

Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex.

It is suggested that the blockade of an exacerbated 5-HT release in the mPFC induced by NMDA antagonists can be a characteristic of atypical antipsychotic drugs, and it is proposed that D(2)/D(3/D(4) receptor antagonists would act predominantly on a subpopulation of GABAergic interneurons of themPFC, thus enhancing cortical inhibition, which would prevent an excessive glutamatergic transmission.

Psychedelics and schizophrenia

Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit

This work used pharmacological magnetic resonance imaging to map the modulatory effects of the selective 5-HT2AR antagonist Ml00907 on the spatiotemporal patterns of brain activity elicited by acute phencyclidine (PCP) challenge in the rat and highlighted the whole frontoseptohippocampal circuit as a key functional substrate of 5- HT2AR antagonism in normal and disease states.



Serotonin and Hallucinogens

LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.

It is concluded that LSD and DOI, a phenethylamine hallucinogen, act as highly potent partial agonists at cortical 5-HT2A receptors at rat piriform cortical interneurons.

Glutamate receptor dysfunction and schizophrenia.

It is proposed that since N-methyl-D-aspartate receptor hypofunction can cause psychosis in humans and corticolimbic neurodegenerative changes in the rat brain, and since these changes are prevented by certain antipsychotic drugs, including atypical neuroleptic agents, a better understanding of this mechanism may lead to improved pharmacotherapy in schizophrenia.

Hallucinogenic indoleamines: Preferential action upon presynaptic serotonin receptors.

The hypothesis that low doses of indoleamine halluciogens act preferentially upon presynaptic serotonin receptors to inhibit raphe neurons, thus releasing postsynaptic neurons from a tonic inhibitory serotonergic influence is supported.

Rodent data and general hypothesis: antipsychotic action exerted through 5-HT2A receptor antagonism is dependent on increased serotonergic tone

MK-801-induced hyperlocomotion is accompanied by an activation of, but is not fully dependent upon, brain serotonergic systems, an effect that is almost completely counterbalanced by a concomitant inhibitory impact on locomotion, mediated through stimulation of serotonin receptors other than 5-HT2A receptors.

The NMDA antagonist model for schizophrenia: promise and pitfalls.

Subanesthetic doses of ketamine in healthy individuals produce not only paranoia and perceptual alterations but also thought disorder, negative symptoms, cognitive deficits, as well as impairment on a number of electrophysiologic tests known to be abnormal in schizophrenia.